The official Fan Token of Team Vitality.
Team Vitality Fan Token Price
$ 0.001930(--)
VIT Price Chart
No Data
Team Vitality Fan Token Market Information
- $0.00
- --
- --
- --
- 1615
- 2,243.94
- $2.73K
- 1,414,535.00
About Team Vitality Fan Token
Information
| Issue Date | -- | Initial Offering Price | -- |
|---|---|---|---|
| Max Supply | -- | Circulating Supply | 1,414,535.00 |
| Listed Exchanges | 0 | Incentive Mechanism | -- |
| Encryption Algorithm | -- |
Team Vitality Fan Token Price History
| Time | Change | High | Low |
|---|---|---|---|
| 24H | -- | -- | -- |
| 7D | -- | -- | -- |
| 30D | -- | -- | -- |
| All | -- | -- | -- |
Team Vitality Fan Token News
Wall Street Banks Cautious as Crypto Perpetual Futures Arrive
On May 29, 2026, the Commodity Futures Trading Commission (CFTC) issued a landmark order approving the listing of bitcoin perpetual futures on Kalshi, a registered U.S. exchange.Martha Grizzard
Bitcoin Steady at $65K; Fed Decision Set to Determine Path
Bitcoin maintains a stable price near $65,000 as investors prepare for the Federal Open Market Committee (FOMC) meeting scheduled for July 28–29, 2026, making the upcoming policy announcement a critical factor for market participants.Martha Grizzard
Mystery Shiba Inu Rally Hits 36% Fueled by Korean Exchanges
On July 26, 2026, the SHIB token price climbed to $0.0000057, resulting in an increase of approximately $1 billion in total market capitalization within 24 hours.Sherry Cantwell
Learn
What is INVITE? How Does It Integrate with Web3 and SocialFi?
INVITE, recently launched by Bitget, stands out as a social growth tool for Telegram and Ton, powered by UXLINK infrastructure.Martha GrizzardWhat is VITA? How Does VitaDAO Democratize Longevity Research?
VitaDAO allows VITA token holders to participate in decision-making related to project funding, research priorities, and intellectual property management.Cornell Rachel
What Is VITA and How Does VitaDAO Support Longevity Research?
VitaDAO is a decentralized autonomous organization (DAO) focused on advancing early-stage longevity research.Jerry McNeill
